CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- 4 Planned sale Chief Financial Officer sold 16,915 shares at an average $13.16 ($222,589)
- 4 Planned sale Chief Medical Officer sold 3,970 shares at $18.01 ($71,508)
- 4 Planned sale Chief Financial Officer sold 15,959 shares at an average $16.96 ($270,593)
- 4 Planned sale Chief Medical Officer sold 679 shares at $16.00 ($10,864)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 3,166 shares (option exercise)
- 4 Option exercise Director acquired 3,166 shares (option exercise)
- 4 Option exercise Director acquired 3,166 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 21,892 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,241 shares (to pay taxes)
- 4 Option exercise Director acquired 3,166 shares (option exercise)
- 4 Option exercise Director acquired 3,166 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 25,492 shares at $16.15 ($411,607)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 28 · 552 filings